Longitudinal dynamics of symptom networks in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a prospective cohort study - Scorecard - MDSpire

Longitudinal dynamics of symptom networks in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a prospective cohort study

  • By

  • Juan Deng

  • Qin Deng

  • Li Zhang

  • April 30, 2026

  • 0 min

Share

Clinical Scorecard: Temporal Changes in Symptom Networks Among Differentiated Thyroid Cancer Patients Undergoing Radioactive Iodine Treatment: A Prospective Cohort Analysis

At a Glance

CategoryDetail
ConditionDifferentiated Thyroid Cancer (DTC)
Key MechanismsSymptom network dynamics during Radioactive Iodine (RAI) therapy.
Target PopulationPatients with differentiated thyroid cancer undergoing RAI therapy.
Care SettingOncology outpatient and inpatient settings.

Key Highlights

  • Significant changes in symptom network structure observed across treatment phases.
  • Psychological distress consistently showed the highest centrality throughout treatment.
  • Throat/mouth symptoms identified as critical bridges between physical and psychological symptoms.
  • Predictability of treatment-related physical symptoms increased substantially post-treatment.
  • Findings suggest a need for targeted psychological interventions during treatment transitions.

Guideline-Based Recommendations

Diagnosis

  • Confirm diagnosis of differentiated thyroid cancer through pathological evaluation.

Management

  • Implement Radioactive Iodine therapy as part of post-surgical management.

Monitoring & Follow-up

  • Assess symptom networks at multiple timepoints to understand dynamic changes.

Risks

  • Monitor for psychological distress and physical symptoms during RAI therapy.

Patient & Prescribing Data

520 patients with differentiated thyroid cancer receiving RAI therapy.

Psychological and physical symptoms co-occur and evolve during treatment.

Clinical Best Practices

  • Utilize network analysis to assess symptom interconnections.
  • Focus on bridge symptoms for potential intervention targets.
  • Provide psychological support during critical treatment transitions.

References

Original Source(s)

Related Content